UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact

Expert opinion on drug metabolism & toxicology, 2024-06, Vol.20 (6), p.491-502

2024

Volltextzugriff (PDF)

Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor

Expert opinion on drug discovery, 2020-05, Vol.15 (5), p.551-560

Sadar, Marianne D.

2020

Volltextzugriff (PDF)

Current androgen receptor antagonists under investigation for resistant prostate cancer

Expert review of anticancer therapy, 2022-02, Vol.22 (2), p.191-202

2022

Volltextzugriff (PDF)

Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directions

Expert opinion on investigational drugs, 2018-10, Vol.27 (10), p.811-822

2018

Volltextzugriff (PDF)

A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer

Research and reports in urology, 2021-01, Vol.13, p.457-472

2021

Volltextzugriff (PDF)

Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery

Expert opinion on therapeutic targets, 2016-10, Vol.20 (10), p.1267-1282

2016

Volltextzugriff (PDF)

AndroPred: an artificial intelligence-based model for predicting androgen receptor inhibitors

Journal of biomolecular structure & dynamics, 2024-09, Vol.42 (14), p.7340-7348

2024

Volltextzugriff (PDF)

Darolutamide (ODM-201) for the treatment of prostate cancer

Expert opinion on pharmacotherapy, 2017-06, Vol.18 (9), p.945-952

Shore, Neal D.

2017

Volltextzugriff (PDF)

Androgen receptor antagonists: a patent review (2008 - 2011)

Expert opinion on therapeutic patents, 2012-05, Vol.22 (5), p.541-565

2012

Volltextzugriff (PDF)

Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials

Expert opinion on investigational drugs, 2020-08, Vol.29 (8), p.881-891

2020

Volltextzugriff (PDF)

Apalutamide for the treatment of prostate cancer

Expert review of anticancer therapy, 2018-09, Vol.18 (9), p.823-836

2018

Volltextzugriff (PDF)

18-Year-old patient with Klinefelter syndrome (47, XXY) and complete androgen insensitivity syndrome (CAIS) - case report

Gynecological endocrinology, 2021-06, Vol.37 (6), p.572-575

2021

Volltextzugriff (PDF)

Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression

Autophagy, 2017-03, Vol.13 (3), p.506-521

2017

Volltextzugriff (PDF)

A concise review of testosterone and bone health

Clinical interventions in aging, 2016-01, Vol.11, p.1317-1324

2016

Volltextzugriff (PDF)

Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer

Drug design, development and therapy, 2012, Vol.6 (default), p.13-18

2012

Volltextzugriff (PDF)

SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic model of castrate-resistant prostate cancer

Cell cycle (Georgetown, Tex.), 2023-08, Vol.22 (14-16), p.1759-1776

2023

Volltextzugriff (PDF)

Apalutamide: the established and emerging roles in the treatment of advanced prostate cancer

Expert opinion on investigational drugs, 2018-06, Vol.27 (6), p.553-559

2018

Volltextzugriff (PDF)

Stabilizing Androgen Receptor in Mitosis Inhibits Prostate Cancer Proliferation

Cell cycle (Georgetown, Tex.), 2007-03, Vol.6 (6), p.647-651

2007

Volltextzugriff (PDF)

Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer

Journal of extracellular vesicles, 2021-08, Vol.10 (10), p.e12136-n/a

2021

Volltextzugriff (PDF)

MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR

Cancer biology & therapy, 2020-01, Vol.21 (1), p.34-42

2020

Volltextzugriff (PDF)

Androgen insensitivity syndrome

Gynecological endocrinology, 2013-01, Vol.29 (1), p.1-5

2013

Volltextzugriff (PDF)

Little support for a protective effect of ADT against COVID-19

Scandinavian journal of urology, 2022-04, Vol.56 (2), p.112-113

Josefsson, Andreas

2022

Volltextzugriff (PDF)

MYRF mutation leads to a single manifestation of sexual development and mimics partial androgen insensitivity syndrome: a case report and literature review

Gynecological endocrinology, 2024-03, Vol.40 (1), p.2331072-2331072

2024

Volltextzugriff (PDF)

Androgen receptor expression and its prognostic value in T1N0 luminal/HER2- breast cancer

Future oncology (London, England), 2022-05, Vol.18 (14), p.1745-1756

2022

Volltextzugriff (PDF)

Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival

Molecular and Cellular Biology, 2012-01, Vol.32 (2), p.399-414

2012

Volltextzugriff (PDF)

1 – 25 von 2.804

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.728)
Mit Volltextzugriff
(1.953)

Publikationsform

Artikel
(2.800)
Reviews
(4)

Sprache

Englisch
(2.802)
Französisch
(1)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.278)
Life Sciences & Biomedicine
(2.268)
Humans
(1.750)
Male
(1.297)
Androgens
(1.158)
Female
(706)
Prostate Cancer
(692)
Animals
(528)
Endocrinology & Metabolism
(502)
Oncology
(450)
Testosterone
(434)
Adult
(415)
Obstetrics & Gynecology
(383)
Middle Aged
(368)
Aged
(311)
Pharmacology & Pharmacy
(308)
Androgen Receptor
(302)
Biological And Medical Sciences
(298)
Prostatic Neoplasms - Drug Therapy
(263)
Receptors, Androgen - Metabolism
(258)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact

Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor

Current androgen receptor antagonists under investigation for resistant prostate cancer

Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directions

A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer

Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery

AndroPred: an artificial intelligence-based model for predicting androgen receptor inhibitors

Darolutamide (ODM-201) for the treatment of prostate cancer

Androgen receptor antagonists: a patent review (2008 - 2011)

Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials

Apalutamide for the treatment of prostate cancer

18-Year-old patient with Klinefelter syndrome (47, XXY) and complete androgen insensitivity syndrome (CAIS) - case report

Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression

A concise review of testosterone and bone health

Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer

SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic model of castrate-resistant prostate cancer

Apalutamide: the established and emerging roles in the treatment of advanced prostate cancer

Stabilizing Androgen Receptor in Mitosis Inhibits Prostate Cancer Proliferation

Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer

MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR

Androgen insensitivity syndrome

Little support for a protective effect of ADT against COVID-19

MYRF mutation leads to a single manifestation of sexual development and mimics partial androgen insensitivity syndrome: a case report and literature review

Androgen receptor expression and its prognostic value in T1N0 luminal/HER2- breast cancer

Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival

Aktive Filter

Suchergebnisse filtern